Biosimilars 

• Biosimilar Operational Readiness: Marketplace Trends and Regulatory Considerations

• Biosimilar Operational Readiness: Managed Care Stakeholder Response to Market Expansion Impact

Drugs, Diseases, and the Managed Care Impact 

• Implementation of a Novel Oncology Home Infusion Model

• Specialty Pharmaceuticals in Development

• Obstacles to Ending HIV Epidemic Risk and Burden of Suboptimal Care

• Oncology Pipeline: Shaping 2023 and Beyond

Legislative and Regulatory Trends 

• Understanding the 340B Program: Policy, Patients, and Practical Implications for Managed Care Pharmacists

• PBM and Healthcare Reform Legislation

• Industry Landscape: The Road Ahead for the Inflation Reduction Act

Focus on Managed Care Pharmacy 

• Navigating NASH: A Discussion on Clinical Background Patient Advocacy and Managed Care Considerations

• Optimizing Value Assessment Tools for Coverage and Reimbursement Decisions: Promises and Pitfalls

• Evaluating Coverage for Digital Therapeutics: A Case Study